Making ablation
of atrial fibrillation
safe, easy, and effective
Our “single-shot” ablation catheter was designed with versatility in mind. This unique catheter can be used for radiofrequency (RFA) and pulsed-field ablation (PFA).
What is unique about EP Frontiers' AFib device?
WHO WE ARE
ElectroPhysiology Frontiers is a MedTech company that has developed an innovative, easy to use “single-shot” catheter ablation system to provide durable ablations and reduce the rate of recurrence of Atrial Fibrillation (AFib) after pulmonary vein isolation (PVI).
OUR HISTORY
The journey of ElectroPhysiology Frontiers began in 2019 when the company was formed by TechWald Holding S.p.A.
EPF later received additional investments to further assist us in advancing our mission.
MEET OUR TEAM
As innovation is complex and frequently challenging, EPF has built a leadership team with a proven track record of success. The team is a diverse group of internationally recognized and accomplished professionals with decades of experience in cardiac electrophysiology, catheter ablation and clinical trials.
Chief Executive Officer
Chief Operating Officer
Clinical & Regulatory Affairs
Quality & Compliance
Chief Technology Officer
Operations & Program Management
Chief Medical Officer
WHAT CLINICIANS HAVE TO SAY
Jonathan P. Piccini, MD, MHS, FACC, FAHA, FHRS
Associate Professor of MedicineDirector, Cardiac Electrophysiology
Duke University Medical Center
Duke University Medical Center
